News
Athenahealth on Tuesday announced it will offer Abridge's artificial intelligence scribing tool to its network of more than ...
Abridge picked up $250 million in series D funding back in February at a reported valuation of $2.75 billion. The company has raised more than $460 million, according to public records.
Abridge was recently awarded Best in KLAS for Ambient AI segment in addition to other accolades, including TIME Best Inventions of 2024, 2024 Forbes AI 50 List, and Fortune’s 2024 AI 50 ...
SAN FRANCISCO, February 17, 2025--Abridge, the leading generative AI platform for clinical conversations, has raised a $250 million Series D investment, coinciding with the milestone of surpassing ...
Abridge, founded in 2018, chose a different path from the start. Led by CEO, founder and practicing cardiologist Shiv Rao, MD, Abridge has emerged as a hard-to-miss leader in ambient clinical ...
(Bloomberg) -- Abridge AI Inc., a startup that uses artificial intelligence to transcribe medical conversations, is raising $300 million in a new funding round led by Andreessen Horowitz ...
Abridge has its share of VC-backed competitors, including Ambience, Nabla, and Suki, plus Microsoft’s Nuance.But Somesh Dash, ...
Abridge, a startup that uses artificial intelligence to build medical documents, said on Monday it raised $250 million in a funding round co-led by Elad Gil and IVP. Skip to main content.
Abridge 1 minute read These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
The deployment is one of Abridge’s largest health system partnerships, said CEO Shiv Rao. The product will be available to 4,000 employed physicians and advanced practice providers.
Corewell and Abridge partnered for a 90-day pilot program with a select group of about 100 providers and found 90% reported a significant increase in the undivided attention they were able to give ...
Abridge uses AI to draft clinical notes in real time as doctors consensually record their visits with patients. The startup is part of a red-hot market that has exploded as health-care executives ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results